Abstract

The liver is a common host organ for cancer, either through lesions that arise in liver epithelial cells [e.g., hepatocellular carcinoma (HCC)] or as a site of metastasis by tumors arising in other organs (e.g., colorectal cancer). However, the changes that occur in liver stromal cells in response to cancer have not been fully characterized, nor has it been determined whether the different sources of liver cancer induce distinct stromal changes. Here, we performed single-cell profiling of liver stromal cells from mouse models of induced spontaneous liver cancer or implanted colorectal liver metastases, with a focus on tumor endothelial cells (ECs). While ECs in liver tissue adjacent to cancerous lesions (so-called adjacent normal) corresponded to liver zonation phenotypes, their transcriptomes were also clearly altered by the presence of a tumor. In comparison, tumor EC transcriptomes show stronger similarities to venous than sinusoidal ECs. Further, tumor ECs, independent of tumor origin, formed distinct clusters displaying conserved “tip-like” or “stalk-like” characteristics, similar to ECs from subcutaneous tumors. However, they also carried liver-specific signatures found in normal liver ECs, suggesting an influence of the host organ on tumor ECs. Our results document gene expression signatures in ECs in liver cancer and show that the host organ, and not the site of tumor origin (liver versus colorectal), is a primary determinant of EC phenotype. In addition, primarily in tumors, we further defined a cluster of chimeric cells that expressed both myeloid and endothelial cell markers and might play a role in tumor angiogenesis.

Highlights

  • The liver is a common host organ for cancer

  • Consistent with the structure of the liver vasculature, we were able to annotate these subpopulations with consensus markers as central vein (CV) endothelial cells (ECs) [7], sinusoidal ECs (SEC) [8, 9] and portal vein (PV) ECs (Fig. 1c)

  • Gene signatures distinctive to tumor ECs are highlighted by dashed boxes. c Functions enriched in genes preferentially expressed by intrahepatic HT-29 tumor ECs compared to s.c

Read more

Summary

Introduction

Tumors in the liver occur either spontaneously through lesions that arise in liver epithelial cells (e.g., hepatocellular and cholangiocarcinomas), or by metastatic spread from primary tumors in other organs (e.g., colorectal cancer). Even though tumors in the liver are quite common, the changes that occur in liver stromal cells in response to tumors have not been well. Regeneron Pharmaceuticals, 777 Old Saw Mill River Rd, Tarrytown, NY 10591, USA characterized. Neither has it been determined whether the different cancer types in the liver induce distinct stromal changes. Studies using single cell transcriptome profiling in various tumor types have revealed extensive heterogeneity in tumor cells and tumor-associated stromal cells, including endothelial cells (ECs), fibroblasts, smooth muscle cells and immune cells [1,2,3]. A comprehensive analysis of bulk RNA profiling from tumor, adjacent normal, Angiogenesis (2020) 23:581–597 and naïve (non-tumor-bearing) tissue, using the GTEx and TCGA datasets, revealed that so-called normal adjacent tissue presents an intermediate state between naïve/healthy and tumor [6], suggesting a strong effect of a tumor on the non-tumor portion of the organ

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call